These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8718500)

  • 1. 3,4-dihydroxyphenylalanine (DOPA) metabolism in screening-detected and non-screening-detected neuroblastoma.
    Ikeda H; Suzuki N; Takahashi A; Kuroiwa M; Matsuyama S
    Pediatr Hematol Oncol; 1996; 13(1):21-32. PubMed ID: 8718500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3,4-dihydroxyphenylalanine (DOPA) decarboxylase deficiency and resultant high levels of plasma DOPA and dopamine in unfavorable neuroblastoma.
    Ikeda H; Matsuyama S; Suzuki N; Takahashi A; Kuroiwa M
    Hypertens Res; 1995 Jun; 18 Suppl 1():S209-10. PubMed ID: 8529065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3,4-dihydroxyphenylalanine (dopa) metabolism and retinoic acid induced differentiation in human neuroblastoma.
    Ikeda H; Pastuszko A; Ikegaki N; Kennett RH; Wilson DF
    Neurochem Res; 1994 Dec; 19(12):1487-94. PubMed ID: 7877718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma dopa and catecholamines in the diagnosis and follow-up of children with neuroblastoma.
    Alvarado CS; Faraj BA; Kim TH; Camp VM; Bain RP; Ragab AH
    Am J Pediatr Hematol Oncol; 1985; 7(3):221-7. PubMed ID: 3934994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma.
    Eldrup E; Clausen N; Scherling B; Schmiegelow K
    Scand J Clin Lab Invest; 2001; 61(6):479-90. PubMed ID: 11681538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined measurements of plasma aromatic L-amino acid decarboxylase and DOPA as tumour markers in diagnosis and follow-up of neuroblastoma.
    Boomsma F; Ausema L; Hakvoort-Cammel FG; Oosterom R; Man in't Veld AJ; Krenning EP; Hahlen K; Schalekamp MA
    Eur J Cancer Clin Oncol; 1989 Jul; 25(7):1045-52. PubMed ID: 2503383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catecholamine metabolism in neuroblastoma.
    LaBrosse EH; Comoy E; Bohuon C; Zucker JM; Schweisguth O
    J Natl Cancer Inst; 1976 Sep; 57(3):633-8. PubMed ID: 10450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopa-release from mouse neuroblastoma clone N 1 E-115 into the culture medium. A test for tyrosine hydroxylase activity.
    Bräutigam M; Dreesen R; Herken H
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Aug; 320(2):85-9. PubMed ID: 6126821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DOPA metabolism in neuroblastoma.
    Helson L; Johnson GA; Smith R
    Med Pediatr Oncol; 1980; 8(4):317-22. PubMed ID: 6779102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometry DNA ploidy analysis and catecholamine secretion profiles in neuroblastoma.
    Abramowsky CR; Taylor SR; Anton AH; Berk AI; Roederer M; Murphy RF
    Cancer; 1989 May; 63(9):1752-6. PubMed ID: 2702581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mRNAs of tyrosine hydroxylase and dopa decarboxylase but not of GD2 synthase are specific for neuroblastoma minimal disease and predicts outcome for children with high-risk disease when measured at diagnosis.
    Träger C; Vernby A; Kullman A; Ora I; Kogner P; Kågedal B
    Int J Cancer; 2008 Dec; 123(12):2849-55. PubMed ID: 18814238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital hyperinsulinism: pancreatic [18F]fluoro-L-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion.
    de Lonlay P; Simon-Carre A; Ribeiro MJ; Boddaert N; Giurgea I; Laborde K; Bellanné-Chantelot C; Verkarre V; Polak M; Rahier J; Syrota A; Seidenwurm D; Nihoul-Fékété C; Robert JJ; Brunelle F; Jaubert F
    J Clin Endocrinol Metab; 2006 Mar; 91(3):933-40. PubMed ID: 16403819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of catecholamine biosynthesis by carbidopa and metyrosine in neuroblastoma.
    Anton AH; Crumrine RS; Stern RC; Izant RJ
    Pediatr Pharmacol (New York); 1983; 3(2):107-17. PubMed ID: 6425794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-dopa inhibits complex IV of the electron transport chain in catecholamine-rich human neuroblastoma NB69 cells.
    Pardo B; Mena MA; de Yébenes JG
    J Neurochem; 1995 Feb; 64(2):576-82. PubMed ID: 7830050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanogenesis in cultured human neuroblastomas.
    Aubert C; Janiaud P; Rouge F; Hansson C; Rorsman H; Rosengren E
    Ann Clin Res; 1980 Dec; 12(6):288-94. PubMed ID: 6786205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenomedullary secretion of DOPA, catecholamines, catechol metabolites, and neuropeptides.
    Chritton SL; Chinnow SL; Grabau C; Dousa MK; Lucas D; Roddy D; Yaksh TL; Tyce GM
    J Neurochem; 1997 Dec; 69(6):2413-20. PubMed ID: 9375673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioenzymatic assay of DOPA (3,4-dihydroxyphenylalanine).
    Johnson GA; Gren JM; Kupiecki R
    Clin Chem; 1978 Nov; 24(11):1927-30. PubMed ID: 709823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms.
    Cumming P; Gjedde A
    Synapse; 1998 May; 29(1):37-61. PubMed ID: 9552174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
    Fiebrich HB; Brouwers AH; Kerstens MN; Pijl ME; Kema IP; de Jong JR; Jager PL; Elsinga PH; Dierckx RA; van der Wal JE; Sluiter WJ; de Vries EG; Links TP
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopa decarboxylase activity of the living human brain.
    Gjedde A; Reith J; Dyve S; Léger G; Guttman M; Diksic M; Evans A; Kuwabara H
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2721-5. PubMed ID: 1688340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.